1. Home
  2. LUNG vs FBLA Comparison

LUNG vs FBLA Comparison

Compare LUNG & FBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • FBLA
  • Stock Information
  • Founded
  • LUNG 1995
  • FBLA 1908
  • Country
  • LUNG United States
  • FBLA United States
  • Employees
  • LUNG N/A
  • FBLA N/A
  • Industry
  • LUNG Industrial Specialties
  • FBLA
  • Sector
  • LUNG Health Care
  • FBLA
  • Exchange
  • LUNG Nasdaq
  • FBLA NYSE
  • Market Cap
  • LUNG 251.5M
  • FBLA 247.4M
  • IPO Year
  • LUNG 2020
  • FBLA N/A
  • Fundamental
  • Price
  • LUNG $6.23
  • FBLA $12.20
  • Analyst Decision
  • LUNG Buy
  • FBLA
  • Analyst Count
  • LUNG 6
  • FBLA 0
  • Target Price
  • LUNG $11.92
  • FBLA N/A
  • AVG Volume (30 Days)
  • LUNG 252.9K
  • FBLA 217.7K
  • Earning Date
  • LUNG 02-19-2025
  • FBLA 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • FBLA N/A
  • EPS Growth
  • LUNG N/A
  • FBLA N/A
  • EPS
  • LUNG N/A
  • FBLA N/A
  • Revenue
  • LUNG $79,302,000.00
  • FBLA $79,358,000.00
  • Revenue This Year
  • LUNG $22.26
  • FBLA N/A
  • Revenue Next Year
  • LUNG $18.72
  • FBLA N/A
  • P/E Ratio
  • LUNG N/A
  • FBLA N/A
  • Revenue Growth
  • LUNG 22.34
  • FBLA 19.62
  • 52 Week Low
  • LUNG $5.46
  • FBLA $11.60
  • 52 Week High
  • LUNG $14.84
  • FBLA $12.74
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.37
  • FBLA N/A
  • Support Level
  • LUNG $5.72
  • FBLA N/A
  • Resistance Level
  • LUNG $6.28
  • FBLA N/A
  • Average True Range (ATR)
  • LUNG 0.40
  • FBLA 0.00
  • MACD
  • LUNG -0.03
  • FBLA 0.00
  • Stochastic Oscillator
  • LUNG 19.85
  • FBLA 0.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About FBLA FB BANCORP INC

FB Bancorp Inc is a holding company. It operates through its subsidiary Fidelity Bank. Fidelity business consists primarily of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market areas. Its services also include residential construction loans, commercial real estate loans (which includes commercial mortgage, commercial construction and land development loans), commercial loans (which includes commercial and industrial, small business and other commercial loans not secured by real estate), home equity loans and lines of credit, and consumer loans.

Share on Social Networks: